Insmed | INSM - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Cytokinetics USD -206.03M 23M 2026-03
DBV Technologies USD -47.4M 14.24M 2026-03
Gilead Sciences USD -7.53B 10.11B 2026-06
Heron Therapeutics USD -2.95M 14.54M 2025-12
Insmed USD -11.37M 150.72M 2026-06
Novartis USD 3.84B 1.33B 2026-03
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Sarepta Therapeutics USD -1.75M 344.92M 2026-06
Ultragenyx Pharmaceutical USD -91M 93M 2026-06
Vertex Pharmaceuticals USD 1.39B 138.9M 2026-06